open access

Vol 4, No 1 (2007)
Review paper
Published online: 2007-02-20
Get Citation

Mood-stabilizing drugs in various types of bipolar affective illness

Janusz Rybakowski
Psychiatria 2007;4(1):1-7.

open access

Vol 4, No 1 (2007)
Prace poglądowe - nadesłane
Published online: 2007-02-20

Abstract

Mood-stabilizing drug should exert a therapeutic and/or prophylactic action in both psychopathological poles of bipolar affective illness. Mood stabilizers can be divided into 1st generation (lithium, valproates and carbamazepine) and 2nd generation (some atypical neuroleptics and lamotrigine). First generation mood stabilizers were introduced at the turn of the 1960s and 1970s, while mood-stabilizing properties of atypical neuroleptics were suggested at the mid-1990s, and those of lamotrigine - at the turn of century.
Mood-stabilizing drugs form the cornerstone of treatment of bipolar affective illness at all stages of its course. Individual mood stabilizers exert different therapeutic and prophylactic effect in depression and mania. In this paper, a review of studies has been done aiming at defining a category of patients especially susceptible or resistant for the treatment with lithium, carbamazepine, valproate, clozapine, olanzapine, quetiapine or lamotrigine in mania, depression and in the prophylaxis of recurrences in bipolar affective disorders.

Abstract

Mood-stabilizing drug should exert a therapeutic and/or prophylactic action in both psychopathological poles of bipolar affective illness. Mood stabilizers can be divided into 1st generation (lithium, valproates and carbamazepine) and 2nd generation (some atypical neuroleptics and lamotrigine). First generation mood stabilizers were introduced at the turn of the 1960s and 1970s, while mood-stabilizing properties of atypical neuroleptics were suggested at the mid-1990s, and those of lamotrigine - at the turn of century.
Mood-stabilizing drugs form the cornerstone of treatment of bipolar affective illness at all stages of its course. Individual mood stabilizers exert different therapeutic and prophylactic effect in depression and mania. In this paper, a review of studies has been done aiming at defining a category of patients especially susceptible or resistant for the treatment with lithium, carbamazepine, valproate, clozapine, olanzapine, quetiapine or lamotrigine in mania, depression and in the prophylaxis of recurrences in bipolar affective disorders.
Get Citation

Keywords

bipolar affective illness; mood stabilizer; mania; depression; prophylaxis of recurrences; lithium; carbamazepine; valproate; atypical neuroleptic drugs; lamotrigine

About this article
Title

Mood-stabilizing drugs in various types of bipolar affective illness

Journal

Psychiatria (Psychiatry)

Issue

Vol 4, No 1 (2007)

Article type

Review paper

Pages

1-7

Published online

2007-02-20

Bibliographic record

Psychiatria 2007;4(1):1-7.

Keywords

bipolar affective illness
mood stabilizer
mania
depression
prophylaxis of recurrences
lithium
carbamazepine
valproate
atypical neuroleptic drugs
lamotrigine

Authors

Janusz Rybakowski

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest Via Medica sp. z o.o. sp. komandytowa, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl